Microbial biofilms are structured communities of microorganisms that adhere to surfaces and are embedded in a self-produced extracellular matrix, playing a significant role in various chronic infections. This book deals with the biology of biofilm formation, their resistance to antimicrobial treatments, and their impact on diseases such as cystic fibrosis, chronic wounds, and medical device-related infections. It explores the latest research on disrupting biofilms and developing therapies to enhance treatment efficacy. Through detailed discussions and case studies, the book provides valuable insights for microbiologists, infectious disease specialists, and clinicians seeking to understand and address the challenges posed by microbial biofilms in disease and therapy. It emphasizes the importance of innovative approaches in combating biofilm-associated infections.
Hazel Reed is a microbiologist specializing in microbial biofilms and their role in disease and therapy. Her research investigates how biofilms form, their resistance to antimicrobial treatments, and their involvement in chronic infections such as those in the lungs, wounds, and medical devices. Hazel has published extensively on the mechanisms of biofilm development, intercellular communication within biofilms, and strategies to disrupt biofilms for therapeutic purposes. She has edited comprehensive guides that explore the clinical implications of biofilms and novel approaches to managing biofilm-associated infections. Hazel’s work is essential in developing effective treatments for biofilm-related diseases, enhancing patient care and infection control.